Skip to content

Alembic Pharma shares surge 5% on USFDA product approvals

Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.

Read More

​ Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments. Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish